Compare GDHG & POM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GDHG | POM |
|---|---|---|
| Founded | 2008 | 2015 |
| Country | China | China |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Other Specialty Stores |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.5M | 38.8M |
| IPO Year | 2023 | 2025 |
| Metric | GDHG | POM |
|---|---|---|
| Price | $2.09 | $0.29 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 11.6K | ★ 465.8K |
| Earning Date | 07-11-2025 | 12-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $15,288,195.00 | ★ $51,210,721.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 12.13 |
| 52 Week Low | $1.82 | $0.26 |
| 52 Week High | $1,968.41 | $6.43 |
| Indicator | GDHG | POM |
|---|---|---|
| Relative Strength Index (RSI) | 34.93 | N/A |
| Support Level | $1.82 | N/A |
| Resistance Level | $2.27 | N/A |
| Average True Range (ATR) | 0.22 | 0.00 |
| MACD | 0.06 | 0.00 |
| Stochastic Oscillator | 25.64 | 0.00 |
Golden Heaven Group Holdings Ltd is an offshore holding company. Through the operating entities in China, it manages and operates six properties consisting of amusement parks, water parks, and complementary recreational facilities. The parks offer a broad selection of exhilarating and recreational experiences, including both thrilling and family-friendly rides, water attractions, gourmet festivals, circus performances, and high-tech facilities. The firm's revenue is generated from selling access to rides and attractions, charging fees for special event rentals, and collecting regular rental payments from commercial tenants. it opearts in the Cayman Islands, PRC, BVI, and HK.
Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of revenue is derived from the Pharmaceutical supply chain segment.